33
/it/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
Create a timeline
Public Timelines
For education
For educational institutions
For teachers
For students
Cabinet
For educational institutions
For teachers
For students
Open cabinet
FAQ
Ricevere il Premium
Close
Create a timeline
Public timelines
FAQ
About & Feedback
Accordo
Privatezza
FAQ
Support 24/7
Cabinet
Get premium
Donate
Scaricare
Export
Creare una copia
Premium
Integrare nel sito Web
Share
SCLC treatment evolution
Category:
Altro
è stato aggiornato:
4 mar 2020
0
0
260
Autori
Created by
Halocy
Attachments
Comments
Eventi
1942: nitrogen mustard first used [3]
1968: SCLC divided into limited disease (LD) and extensive disease (ED) stages [3]
1969: Cyclophosphamide single-agent chemotherapy shown to be effective [3]
1969: Medical Research Council: superior survival benefit with primary radical radiation therapy compared to surgery [3]
March 2019: Atezolizumab approved as first line treatment for ES-SCLC by FDA
Periodi
1959-1962 Recognition of small cell lung cancer (SCLC) as a separate category from other lung cancers [3]
1970s: Combination therapy shows dramatic responses. Fraction of patients experienced very long-term disease-free survival [3]
1980s: Combination cisplatin/etoposide with chemotherapy becomes treatment of choice [3]
1990s: Chemotherapy used for relapsed disease [4]
2000s: Development and study of new therapeutic targets for SCLC with mixed results [3]
About & Feedback
Accordo
Privatezza
FAQ
Support 24/7
Cabinet
Get premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Comments